戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  genotyping to distinguish new infection and recrudescence.
2 alizing Ab delayed but did not prevent virus recrudescence.
3 phosphamide-induced immunosuppression led to recrudescence.
4 ls altered CNS cellular tropism during viral recrudescence.
5 ed Abs as key effectors in suppressing virus recrudescence.
6  103 implementation units in Ethiopia showed recrudescence.
7 after recovery, potentially indicating viral recrudescence.
8 k for partial parasite clearance and disease recrudescence.
9 the event of rising resistance and treatment recrudescence.
10 dity control goal, there is a high chance of recrudescence.
11 tralizing immunity was a likely cause of the recrudescence.
12  of CD4 T cell dysfunction permits bacterial recrudescence.
13 l immunity is essential for preventing viral recrudescence.
14 an note or discharge summary stated the term recrudescence.
15 tify any genetic changes underlying parasite recrudescence.
16 suppressed hosts, and delay/control of viral recrudescence.
17 ncentrations at baseline, 7 days, and day of recrudescence.
18 re rates were low (45.9%), owing to parasite recrudescence.
19 r these drugs do not represent biomarkers of recrudescence.
20 enched, 37 (46%) of 81 patients had parasite recrudescence.
21 cquired immunity that is lost over time, and recrudescence.
22  and plasma obtained at or just before viral recrudescence.
23  to compare seasonality in EoE diagnosis and recrudescence.
24 to onward transmission and subsequent patent recrudescence.
25 on beyond 6 mo, ensuring vernal reproductive recrudescence.
26 g CD69, CD38/HLA-DR, or PD-1 until after HIV recrudescence.
27  acute viral control and in preventing viral recrudescence.
28 den is one of the early hallmarks of disease recrudescence.
29 d reinfection could either precede or follow recrudescence.
30 cell responses but experienced low-level HCV recrudescence 12 weeks later, when HCV-specific T cells
31 cular, we refine previous estimates of viral recrudescence after ART interruption by accounting for h
32 arasites from entering latency and abolishes recrudescence after ART treatment of infected mice.
33  from a person with coronavirus disease 2019 recrudescence after nirmatrelvir/ritonavir treatment.
34                        To reduce the risk of recrudescence after the goals are achieved, programs hav
35  antibiotic treatment and leads to infection recrudescence after therapy.
36                                Posttreatment recrudescence also did not develop in animals deficient
37                                        Rapid recrudescence also occurred despite broad CD8(+) T-cell
38 reased T cell proliferation with rapid viral recrudescence and a decrease in TREC levels.
39 ce of CD4 T cell help, mice succumb to viral recrudescence and disease.
40 ce is emerging, ten (16%) of 63 patients had recrudescence and in Ratanakiri, where artemisinin resis
41           Using AmpSeq for discrimination of recrudescence and new infection in antimalarial drug tri
42                                         Both recrudescence and reinfection could occur in the same in
43 spite appropriate antimicrobial therapy, but recrudescence and reinfection have previously been diffi
44  and asymptomatic infection and during viral recrudescence and SIV encephalitis.
45 immunity is ineffective in controlling virus recrudescence and suggest that the continued presence of
46 sults show that there is a lag between viral recrudescence and the boosting of ADCC antibodies, which
47 iral therapy (ART) initiation on the rate of recrudescence and the viral load growth rate after treat
48 ghs in malaria chemotherapy that can prevent recrudescences and protect the future of ART-based combi
49 inguish this re-infection from drug failure (recrudescence) and to adjust final drug efficacy estimat
50  such as herpes simplex virus type-2 (HSV-2) recrudescence, are sufficient to induce T cell dysfuncti
51 combined population attributable fraction of recrudescence associated with K13 mutation and Pfmdr1 am
52      Complete clearance of parasites with no recrudescence by day 14.
53 ciparum, reinfections are distinguished from recrudescences by polymerase chain reaction analysis of
54 llance failure followed by gamma-herpesvirus recrudescence can be modeled using murine gamma-herpesvi
55 llance failure followed by gamma-herpesvirus recrudescence can be modeled using murine gamma-herpesvi
56 a quarter of the world's population, and its recrudescence can cause life-threatening disease in immu
57                             Discrepancies in recrudescence classification between match-counting and
58                                              Recrudescence could be prevented by passive transfer of
59 x, and nucleocapsid proteins did not prevent recrudescence, demonstrating that neutralization is crit
60                                              Recrudescence did not occur in any volunteer.
61 ed with pretreatment VL, the amount of viral recrudescence during the treatment interruptions, and th
62 o longer suppressed reproduction and gonadal recrudescence ensued.
63 ated eIF2alpha correlates with high rates of recrudescence following ART, and inhibiting eIF2alpha de
64 ndidate molecular markers predicted parasite recrudescence following dihydroartemisinin-piperaquine t
65 ing an exonuclease, associates with parasite recrudescence following dihydroartemisinin-piperaquine t
66 xistence of a genetic change responsible for recrudescence following fosmidomycin-clindamycin treatme
67 sic interval timer to initiate physiological recrudescence following the winter solstice.
68  the host as fast as possible and to supress recrudescence for as long as possible.
69                       Parasite clearance and recrudescence for up to 63 days of follow-up were assess
70 intact Ab responses, resulted in significant recrudescence from latency, both in the spleen and the l
71 ated antibody was likely indicative of viral recrudescence from latency.
72 flammation in people on ART or prevent viral recrudescence from macrophage reservoirs in strategies t
73 ould enable prompt diagnosis and distinguish recrudescence from mimics, such as transient ischemic at
74 ed and adjusted by genotyping to distinguish recrudescence from new infection) for each episode of un
75 either unadjusted or adjusted to distinguish recrudescence from new infection.
76 s, with or without adjustment to distinguish recrudescence from new infection.
77 requires molecular correction to distinguish recrudescence from new infections by comparing parasite
78 amples, the assay consistently distinguished recrudescence from new infections in 17/20 cases (85%) f
79 stness of nanopore AmpSeq for distinguishing recrudescence from new infections in paired samples from
80 ession, or parturition) to acute disease and recrudescence from persistent SVA infection.
81 sp1, msp2, and glurp was used to distinguish recrudescence from reinfection.
82 g msp-1, msp-2, and glurp for distinguishing recrudescences from reinfections.
83            Distinguishing treatment failure (recrudescence) from reinfection in uncomplicated falcipa
84 SR group (patients who were hospitalized for recrudescence) had more women, African American individu
85 ance of different algorithms for classifying recrudescence, have not been systematically assessed.
86  the seasonality of the initial diagnosis or recrudescence (i.e., food bolus impaction) of EoE.
87 short half-life, and dormant forms can cause recrudescence if not cleared by partner drugs.
88 noquine and atovaquone achieves cure with no recrudescence in both models of human babesiosis.
89 e to therapy had an initial drop followed by recrudescence in ctDNA levels.
90 lay robust switches in tissue involution and recrudescence in mass.
91                              Following viral recrudescence in muMT mice, total CD8(+) T cell numbers
92 s a lower frequency of suspected relapses or recrudescence in patients treated with primaquine compar
93 be considered in order to prevent EBOV viral recrudescence in recovering individuals and thereby to m
94  of viral persistence and associated disease recrudescence in survivors receiving these therapeutics
95                          By pi day 56, viral recrudescence in the brain was detected in 2 of 6 infect
96           The estimates for rates of malaria recrudescence in the three treatment groups were similar
97 ing responses to treatment and in predicting recrudescence is important.
98                                        Viral recrudescence is prevented by the transfer of antiviral
99 -compliance with long treatment regimens and recrudescence) issues that limit their therapeutic poten
100 s that EBOV sGP may be an indicator of viral recrudescence long after recovery from acute EVD.
101                                              Recrudescence occurred a mean (SD) of 3.9 (0.6) years af
102                                  No death or recrudescence occurred by day 180.
103                                              Recrudescence occurred in 7 participants 11-14 days afte
104                                        Viral recrudescence occurred in four of the five Mamu-A*01-pos
105                                        Viral recrudescence occurred within 4 to 9 days, and mice succ
106 f trench fever shows how war can lead to the recrudescence of an infectious disease and how medicine
107  dose on day 100 or after 1 year resulted in recrudescence of anti-pig antibody and graft failure.
108 D8(+) immune T cells significantly inhibited recrudescence of brain cysts during chronic ME49 infecti
109 golimod, drug-induced remission was lost and recrudescence of clinical disease was observed.
110 letion of the full RTX infusion, substantial recrudescence of CLL cells occurs, and these cells have
111 ce of initial NK cell control, there is late recrudescence of disease and mortality in immunodeficien
112 o latent cysts (bradyzoites) responsible for recrudescence of disease.
113                         Fatal brain-confined recrudescence of EBOV infection manifested as severe inf
114 ribution of either the diagnosis or clinical recrudescence of EoE throughout the year.
115 ion between seasonality and diagnosis and/or recrudescence of eosinophilic esophagitis (EoE) remains
116 g virus in other body compartments to permit recrudescence of EVD, has shaken our thinking of what it
117 d 120 postinoculation resulted in a striking recrudescence of fecal virus shedding and the reappearan
118 after the introduction of initial therapy or recrudescence of fever within 7 days, which defined trea
119  response, but her course was complicated by recrudescence of high-grade viral shedding.
120 recurrent, disseminated infection was due to recrudescence of his initial infection rather than reinf
121 ents to clear chronic infection and stop the recrudescence of infection after therapy.
122 lying mechanisms that control latency or the recrudescence of infection that occurs during subsequent
123 had similar expected infection dynamics, and recrudescence of infection was unlikely.
124 n the absence of anti-viral Ab, resulting in recrudescence of infectious virus.
125                                              Recrudescence of latent virus was investigated in blood,
126 e infection, but suffer an ultimately lethal recrudescence of lytic viral replication in the respirat
127 spinal fluid of a patient who then developed recrudescence of meningitis despite treatment with vanco
128                                              Recrudescence of neurotropic coronavirus due to loss of
129 siological mechanism that has been linked to recrudescence of parasites after monotherapy with ART an
130 t failure was associated with reinfection or recrudescence of preexisting infection.
131 e patients develop worsening oxygenation and recrudescence of pulmonary hypertension but, unexpectedl
132                                          The recrudescence of severe invasive group A streptococcal (
133                                            A recrudescence of testes and body mass occurred from mid-
134 elapse was low and did not seem to result in recrudescence of the aggressive clinical picture seen at
135 f refractoriness to melatonin (Mel) triggers recrudescence of the atrophied reproductive apparatus of
136                         Genotyping confirmed recrudescence of the initial parasite populations and dr
137  the DNA vaccine combination did not prevent recrudescence of the latent infection after injection of
138 hich persistence of infection in the mother, recrudescence of the parasite during pregnancy, and the
139 t cessation of heparin therapy can lead to a recrudescence of thrombosis and acute ischemia.
140 pheral blood mononuclear cells suggests that recrudescence of viral replication in brain occurs by re
141                                       Robust recrudescence of viral transcription and protein synthes
142 hocytes in controllers resulted in transient recrudescence of viremia, suggesting that the combinatio
143                                  The risk of recrudescence of VL after scaling down control efforts c
144 al drugs that rapidly clear parasitemia, but recrudescences of the infection frequently follow ART mo
145 approached, and is vital when monitoring for recrudescence once control, or possibly 'elimination', i
146 s revealed that while both result in corneal recrudescence, only UV-B irradiation results in rHSK.
147  baseline by day 15 and failed to rebound at recrudescence or after reinfection.
148  recurrence (23-486 d) was not different for recrudescence or reinfection.
149 es (relapse), blood-stage treatment failure (recrudescence) or reinfection.
150  (relapse), a blood-stage treatment failure (recrudescence), or a newly acquired infection (reinfecti
151  mutation alone was a strong risk factor for recrudescence (P = .009).
152 vious stroke-related deficits (or poststroke recrudescence [PSR]) is an underrecognized and inadequat
153  is delayed results in a 39% increase in the recrudescence rate (95% credible interval: [18%, 62%]),
154                Kaplan-Meier estimates of the recrudescence rate in the intention-to-treat population
155  infection rebound dynamics, and determine a recrudescence rate of once every 2-4 days.
156                                              Recrudescence rates by day 28, after correction by genot
157 ) but not IgA anti-spike Ab suppressed virus recrudescence, reduced viral antigen in most cell types
158  arising from blood-stage treatment failure (recrudescence), reinfection or relapse.
159 include the inability to distinguish between recrudescence, reinfection, and relapse in P. vivax recu
160  relationship between T-cell dysfunction and recrudescence remains uncertain, we propose T cell dysfu
161                             Onset of disease recrudescence results in decreased parasite cyst burden
162 hypnozoites (relapse source) and merozoites (recrudescence source), not hypnozoites only.
163                                              Recrudescence subsequently developed 1) in animals defic
164 MHC expression on glial cells at the time of recrudescence suggested that memory T cells, although fu
165 ing algorithm classified significantly fewer recrudescences than both the >= 2/3 and Bayesian algorit
166 ntrol group (patients who did not experience recrudescence), the PSR group (patients who were hospita
167 a homogenous distribution of episodes of EoE recrudescence throughout the year was noted, with no sig
168 n complete clearance of the parasite with no recrudescence up to 122 d after discontinuation of thera
169 2/glurp combination classified more cases of recrudescence using the >= 2/3 in the dihydroartemisinin
170 msp-1/msp-2/2490 combination identified more recrudescences using the >= 2/3 and 3/3 algorithms in th
171                            Classification of recrudescence versus reinfection is usually based on a c
172 ted Kaplan-Meier risk of P falciparum 42 day recrudescence was 54% (95% CI 45-63) in the modified ITT
173    Although parasitemia levels were similar, recrudescence was more frequent and prolonged, and anemi
174                        The number of days to recrudescence was unrelated to the number of SNPs accumu
175                                              Recrudescences were uncommon, and all occurred after AL
176 ion may thus play a role in preventing viral recrudescence, while increasing the risk of pathological
177                                              Recrudescence with identical or highly phylogenetically

 
Page Top